# Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets

> **NCT03765944** · PHASE1 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 10 (actual)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** sirolimus

## Key facts

- **NCT ID:** NCT03765944
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-05
- **Primary completion:** 2018-12-29
- **Final completion:** 2018-12-29
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03765944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03765944, "Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03765944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*